How do I determine the subtype of small intestinal bacterial overgrowth (SIBO)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Determining SIBO Subtype

Use combined hydrogen and methane breath testing to determine SIBO subtype, as this approach is more effective than hydrogen testing alone and can differentiate between hydrogen-dominant, methane-dominant (now termed intestinal methanogen overgrowth), and mixed patterns. 1

Diagnostic Approach

Primary Testing Method

Breath testing with dual gas analysis is the recommended approach:

  • Perform hydrogen AND methane breath testing together rather than hydrogen alone, as this significantly increases diagnostic accuracy and allows subtype identification 1
  • Use glucose (preferred) or lactulose as substrate 1
  • Glucose breath testing provides greater accuracy with sensitivity ranging from 20-93% and specificity from 30-86% 1
  • Methane measurement is critical because methane-producing organisms (archaea, not bacteria) can cause symptoms even when hydrogen is normal 2, 3

SIBO Subtypes Identified by Breath Testing

The three recognized subtypes are 2, 3:

  • Hydrogen-dominant (H+): Elevated hydrogen production, associated with diarrhea-predominant symptoms and low lactose intake 4
  • Methane-dominant (M+): Now properly termed Intestinal Methanogen Overgrowth (IMO) since methanogens are archaea, not bacteria; associated with constipation, high serum folate, and low fiber/lactose intake 4, 3
  • Hydrogen/Methane-dominant (H+/M+): Mixed pattern with both gases elevated, associated with low vitamin D, low ferritin, and low fiber intake 4

Alternative Diagnostic Methods

Small bowel aspiration with culture remains the gold standard but is rarely necessary 1:

  • Obtain ≥10 mL sterile aspirate from proximal jejunum during upper endoscopy 1
  • Positive if ≥10³ CFU/mL (some sources use ≥10⁵ CFU/mL) 3, 5
  • Qualitative assessment is easier than quantitative and can identify colonic bacteria 1
  • Key technique: Flush 100 mL sterile saline into duodenum, flush channel with 10 mL air, turn down suction, wait seconds, then aspirate into sterile trap 1

Clinical Correlation with Subtypes

Nutritional and Biochemical Patterns

Different subtypes show distinct deficiency patterns 4:

  • H+/M+ subtype: Most likely to have vitamin D deficiency and low ferritin 4
  • M+ subtype (IMO): Associated with elevated folic acid levels 4
  • All subtypes can present with malabsorption, but severity varies 4

Symptom Patterns

  • Methane-positive (IMO): Strongly linked to constipation-predominant IBS 3
  • Hydrogen-positive: More associated with diarrhea and bloating 2
  • Mixed patterns show variable symptoms 4

Important Caveats

Avoid these common pitfalls:

  • Do not use lactose, fructose, or sorbitol as breath test substrates—these test for carbohydrate malabsorption, not SIBO 6
  • Lactulose breath testing has limitations due to effects on small bowel transit and concerns about specificity 1, 6
  • False low fecal elastase may indicate SIBO rather than pancreatic insufficiency, especially if pancreatic enzyme replacement therapy is not tolerated 1
  • Breath tests can be misleading with false negatives compared to culture 1
  • Recent antibiotic use depletes anaerobes and can affect results 1

When Testing is Not Available

If breath testing is unavailable, consider 1:

  • Endoscopic aspiration as described above
  • Empirical antibiotic treatment only when testing is truly not accessible, though this approach lacks validation and risks antibiotic resistance 1

Emerging Understanding

Recent molecular techniques reveal that SIBO is not simply colonic bacteria migrating proximally, but rather overgrowth of specific species, predominantly Escherichia coli and Klebsiella from phylum Proteobacteria 2. This understanding may eventually lead to more targeted subtype-specific therapies 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Modern concepts of small intestinal bacterial overgrowth.

Current opinion in gastroenterology, 2025

Research

Small intestinal bacterial overgrowth: current update.

Current opinion in gastroenterology, 2023

Research

Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.